Shilpa Medicare to acquire 30.4% stake in Spain’s Gate2Brain with €7 million investment

The global glioblastoma treatment market is estimated at approximately $3 billion in 2025 and is projected to exceed $6 billion by 2035. The pediatric brain tumour market is estimated at around $1.5 billion, while the market for DIPG therapies is…








